secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tracon Pharmaceuticals, Inc. (—)
CIK:        0001394319
Form:       8-K
Filed at:   2023-04-20T23:59:59+00:00
Accession:  0000950170-23-013707
Event type: debt
Sentiment:  negative
Materiality: 0.65
Item codes: 1.01, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TRACON amends loan agreement with Runway; authorized shares raised to 60M
-------------------------------------------------------------------------

- Loan Amendment: By April 28, 2023, if company raises ≥$25M net cash, Runway may lend $10M at its discretion; otherwise loan terminates and final payment fee due.
- Charter Amendment filed to increase authorized common stock from 40M to 60M shares, approved by stockholders.
- Stockholders elected Carol Lam, Martin Mattingly, J. Rainer Twiford as directors, approved say-on-pay and frequency of 1 year.
- Stockholders approved issuance of shares to Opaleye L.P. upon exercise of warrants that could exceed 19.99% ownership.
- Ernst & Young ratified as independent auditor for FY2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1394319/000095017023013707/0000950170-23-013707-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1394319/000095017023013707/tcon-20230415.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-013707

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer